Stellantis Restructuring Prediction Market Oversight Oura IPO Lead Morning Market Briefing US Productivity Growth Cools in Q4 as Labor Costs Rise at Faster Pace Disneys The Mandalorian and Grogu Posts Weakest Thursday Previews in Star Wars Franchise History Genpact CEO Warns of AIDriven Reduction in IT Workload and Jobs Republican Attorneys General Break Ranks with House Colleagues on Social Media Legislation Voya Financial Reports Earnings Growth Across All Business Segments Northern Dynasty Minerals Ltd NAK Q3 2025 Earnings Small Positive EPS Surprise as Pebble Project Advances Grupo Aeromexico Q4 2025 Earnings EPS Falls Sharply Short of Estimates as Operational Headwinds Persist OCCI Q1 2026 Earnings Deep EPS Miss Overshadowed by Positive Market Reaction PSBD Q1 2026 Earnings Significant EPS Miss Driven by Unrealized Losses PDS Biotechnology Q1 2026 Earnings EPS Beat on Narrower Loss Clinical Progress in Focus GameStop GME Hovers Near Key Support Levels Amid Modest Gains Bitfarms BITF Holds Steady at 198 as Crypto Mining Stock Waits for a Catalyst SiteOne Landscape Supply SITE Slightly Declines as Sector Headwinds Persist Hingham Institution for Savings HIFS Holds Steady After Modest Gain Support and Resistance Levels in Focus Nutex Health NUTX Surges 483 as Bullish Momentum Targets Key Resistance Quantum Computing Stocks Surge on US Governments 2 Billion Funding Plan HLIT Q1 2026 Earnings EPS Smashes Estimates Driving DoubleDigit Stock Surge Gladstone Commercial Preferred GOODO Holds Steady Near 2023 as Yield Attracts Investors ADAMH Q1 2026 Earnings Strong EPS Surprise Highlights Solid Underlying Performance KALV Q1 2026 Earnings Narrower Loss Beats Expectations Clinical Pipeline Progress Underway BNED Q4 2025 Earnings Loss Narrows More Than Expected Shares Rise BWXT Q1 2026 Earnings EPS Surge Highlights Strong Operational Execution Mercantile Bank Corporation MBWM Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise Amidst Modest Share Decline Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline STRO Q1 2026 Earnings Narrowing Losses Beat Estimates Stock Gains 7